Sabine Fiala-Buskies

Safety and effectiveness of regorafenib in patients with metastatic colorectal cancer in routine clinical practice in the prospective, observational CORRELATE study

Michel Ducreux, Lone Nørgård Pétersen, Leopold Öhler et al. · European Journal of Cancer · 2019 · 75 citations · Full text

Exposure–response relationship of regorafenib efficacy in patients with hepatocellular carcinoma

Alexander Solms, Isabel Reinecke, Sabine Fiala-Buskies et al. · European Journal of Pharmaceutical Sciences · 2017 · 18 citations · Full text

Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan

Kun‐Huei Yeh, Tsai‐Sheng Yang, Tzu‐Chi Hsu et al. · Journal of the Formosan Medical Association · 2021 · 15 citations · Full text

Clinical efficacy and safety of regorafenib (REG) in the treatment of metastatic colorectal cancer (mCRC) in daily practice in Germany: Final results of the prospective multicentre non-interventional RECORA study.

H. Schulz, U.P. Strauss, Markus Langen et al. · Journal of Clinical Oncology · 2018 · 15 citations

Surgical Oncology, Colorectal Surgery, Cancer Management +24

Regorafenib in patients with unresectable hepatocellular carcinoma (uHCC) in routine clinical practice: Interim analysis of the prospective, observational REFINE trial.

Ho Yeong Lim, Philippe Merle, Richard S. Finn et al. · Journal of Clinical Oncology · 2020 · 12 citations

Cancer Management, Pathology, Pharmacotherapy +20